PerkinElmer Reaches Deal for $1.5B Credit Facility
The agreement is for a new credit facility, which replaces one from 2019 that provided for a $1 billion unsecured revolving credit facility.
PerkinElmer Enters $500M Credit Facility
The proceeds will be used to pay, in part, PerkinElmer's $5.25B acquisition of BioLegend, announced last month.
Sema4 Raises $121M in Series C Financing Round
BlackRock, the world's largest investment manager, led the round, joined by new investors Deerfield Management and Moore Strategic Ventures as well as existing investors.
Adaptive Biotechnologies to Raise $240M in Public Stock Offering
The offering consists of 8 million shares at an offering price of $40 per share, of which 2 million are being sold by a shareholder.
Adaptive Biotechnologies Prices Public Offering of Stock
The Seattle-based immune sequencing firm will not receive any proceeds from the sale of the shares.